Many medical device manufacturers have found themselves caught in a trap where there is a DRG and/or ZE (add-on payment) available for their technology but where the insurance companies refuse to pay this fee.
Through our joint work with Dr Martin Braun we have now found a way to resolve this.
It requires the ability to demonstrate good comparative effectiveness. If you only have single arm studies, we have the ability to extend your data with another cohort to demonstrate comparative effectiveness through our real world evidence (RWE) services.
With Dr Braun we are also able to help you address other aspects of the DRG, ZE or NUB issues in Germany.
If you are interested in this, please choose a time for a call with our CEO, Mattias Kyhlstedt: https://calendly.com/mattias-kyhlstedt